BetterLife Pharma Inc.
BETRF
$0.22
$0.000.14%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -58.70% | 4.82% | 18.09% | -141.87% | 71.26% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 307.01% | -276.05% | 174.04% | 65.73% | 59.53% |
| Change in Net Operating Assets | 231.27% | -84.90% | -15.04% | -3.08% | -66.79% |
| Cash from Operations | 44.44% | -3,560.47% | 93.14% | -1,154.00% | 25.93% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | 0.00% | -77.78% | -- | -- | -- |
| Issuance of Common Stock | 435.89% | -- | -100.00% | 500.00% | 187.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -41.35% | 24,546.15% | -101.02% | 623.86% | 188.52% |
| Foreign Exchange rate Adjustments | -80.00% | 225.00% | -233.33% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 244.12% | 133.33% | -543.48% | -69.74% | 202.70% |